Loading…
Based on limited metadata, the FDA issued a warning letter to Life Leaf Medical CBD Center on July 15, 2024, regarding products in the food and/or cosmetics category. Without access to the full letter text or detailed subject information, the specific regulatory violations cannot be determined from the available metadata. The issuing office is also unknown, limiting clarity on which FDA division initiated the enforcement action. Additional documentation would be needed to identify the precise nature of the compliance concerns.